Snake venom Lys49 myotoxins: From phospholipases A 2 to non-enzymatic membrane disruptors

Toxicon

Volumn 60, Issue 4, 2012, Pages 520-530

  Lomonte, Bruno ^a   Rangel, José ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

Lys49; Muscle damage; Myonecrosis; Myotoxin; Phospholipase A 2 homologue; Snake venom

Indexed keywords

ASPARTIC ACID; LYSINE; PHOSPHOLIPASE A2; SNAKE VENOM;

AMINO ACID SUBSTITUTION; ARTICLE; CELL DEATH; ENVENOMATION; ENZYME ACTIVE SITE; HUMAN; LIPID HYDROLYSIS; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; MUSCLE NECROSIS; NONHUMAN; PRIORITY JOURNAL; SARCOLEMMA; SKELETAL MUSCLE; STRUCTURE ACTIVITY RELATION; TOXICOLOGY; TOXIN STRUCTURE;

ANIMALS; ASPARAGINE; CELL MEMBRANE; CROTALID VENOMS; DIMERIZATION; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LYSINE; MUSCLE, SKELETAL; NECROSIS; NEUROTOXINS; PHOSPHOLIPASES A2; STRUCTURE-ACTIVITY RELATIONSHIP; VIPERIDAE;

VIPERIDAE;

EID: 84863784371     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2012.02.007     Document Type: Article

References (113)

1. 2 activity based on ligand-induced conformational change. J. Biol. Chem. 2005, 280:7326-7335.
2. 2 myotoxins from crotalid snake venoms. Cell Biochem. Funct. 2005, 23:307-313.
3. 2 homologue. Int. J. Biochem. Cell Biol. 2002, 34:1268-1278.
4. 2 homologues are reduced, but not abolished, by a pH-induced dissociation. Toxicon 2005, 46:291-296.
5. 2 from Bothrops jararacussu. Toxicon 2008, 51:538-546.
6. 2 - a structural review. Toxicon 1996, 34:827-841.
7. Arni R.K., Ward R.J., Gutiérrez J.M., Tulinsky A. Structure of a calcium-independent phospholipase-like myotoxic protein from Bothrops asper venom. Acta Cryst. D 1995, 51:311-317.
8. 2 homologue isolated from the venom of Cerrophidion (Bothrops) godmani. Archs. Biochem. Biophys. 1999, 366:177-182.
9. Azevedo-Marques M.M., Cupo P., Coimbra T.M., Hering S.E., Rossi M.A., Laure C.J. Myonecrosis, myoglobinuria and acute renal failure induced by South American rattlesnake (Crotalus durissus terrificus) envenomation in Brazil. Toxicon 1985, 23:631-636.
10. Bober M.A., Glenn J.L., Straight R.C., Ownby C.L. Detection of myotoxin a-like proteins in various snake venoms. Toxicon 1988, 26:665-673.
11. Bryan B.A., Walshe T.E., Mitchell D.C., Havumaki J.S., Saint-Geniez M., Maharaj A.S., Maldonado A.E., D'Amore P.A. Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation. Mol. Biol. Cell 2008, 19:994-1006.
12. Buckland A.G., Wilton D.C. Anionic phospholipids, interfacial binding and the regulation of cell functions. Biochim. Biophys. Acta 2000, 1483:199-216.
13. 2 from Bothrops asper snake venom. Archs. Biochem. Biophys. 1998, 358:343-350.
14. Calvete J.J., Juárez P., Sanz L. Snake venomics. Strategy and applications. J. Mass Spectrom. 2007, 42:1405-1414.
15. 2 by sequence analysis and site directed mutagenesis. Toxicon 2003, 42:869-883.
16. 2. Biochem. J. 2002, 366:971-976.
17. 2 by scanning alanine mutagenesis. Biochim. Biophys. Acta 2007, 1768:1247-1257.
18. Cintra-Francischinelli M., Pizzo P., Rodrigues-Simioni L., Ponce-Soto L., Rossetto O., Lomonte B., Gutiérrez J.M., Pozzan T., Montecucco C. Calcium imaging of muscle cells treated with snake myotoxins reveals toxin synergism and presence of receptors. Cell Mol. Life Sci. 2009, 66:1718-1728.
19. 2+ influx in C2C12 myotubes. Toxicon 2010, 55:590-596.
20. Cintra-Francischinelli M., Caccin P., Chiavegato A., Pizzo P., Carmignoto G., Angulo Y., Lomonte B., Gutiérrez J.M., Montecucco C. Bothrops snake myotoxins induce a large efflux of ATP and potassium with spreading of cell damage and pain. Proc. Natl. Acad. Sci. USA 2010, 107:14140-14145.
21. Colston T.J., Costa G.C., Vitt L.J. Snake diets and the deep history hypothesis. Biol. J. Linnean Soc. 2010, 101:476-486.
22. 2 homologue. Prot. Struct. Funct. Genet. 1998, 30:442-454.
23. 2 from snake venom to human secreted forms. J. Mol. Evol. 1990, 31:228-238.
24. 2+-independent membrane damaging activity. Biochemistry 2001, 40:6912-6920.
25. 2. Prot. Pept. Lett. 2009, 16:877-886.
26. de Oliveira A.H.C., Ferreira T.L., Ward R.J. Reduced pH induces an inactive non-native conformation of monomeric bothropstoxin-I (Lys49-PLA2). Toxicon 2009, 54:373-378.
27. 2 from Bothrops neuwiedi venom. Biochimie 2011, 93:513-518.
28. 2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem. Rev. 2011, 111:6130-6185.
29. 2, anticoagulant and myotoxic activities. Biochim. Biophys. Acta 1991, 1070:455-460.
30. 2: role of negatively-charged phospholipids as potential membrane binding sites. Arch. Biochem. Biophys. 2001, 391:56-64.
31. 2 homologues: relevant structural features on myotoxicity and catalytic inactivity. Prot. Pept. Lett. 2009, 16:887-893.
32. 2 from Bothrops genus reveal their myotoxic site. J. Struct. Biol. 2009, 167:106-116.
33. 2 class. Proteins 2010, 79:61-78.
34. Fry B.G., Wüster W. Assembling an arsenal: origin and evolution of the nake venom proteome inferred from phylogenetic analysis of toxin sequences. Mol. Biol. Evol. 2004, 21:870-883.
35. Fry B.G., Vidal N., Normamn J.A., Vonk F.J., Scheib H., Ramjan S.F., Kuruppu S., Fung K., Hedges S.B., Richardson M.K., Hodgson W.C., Ignjatovic V., Summerhayes R., Kochva E. Early evolution of the venom system in lizards and snakes. Nature 2005, 439:584-588.
36. Fry B.G., Vidal N., van der Weerd L., Kochva E., Renjifo C. Evolution and diversification of the Toxicofera reptile venom system. J. Protemics 2009, 72:127-136.
37. 2 homologue binds to vascular endothelial growth factor receptor-2 via C-terminal loop region. Biochem. J. 2008, 411:515-522.
38. 2 homologues. Toxicon 2010, 55:1-11.
39. Germani A., Di Carlo A., Mangoni A., Straino S., Giacinti C., Turrini P., Biglioli P., Capogrossi M.C. Vascular endothelial growth factor modulates skeletal myoblast function. Am. J. Pathol. 2003, 163:1417-1428.
40. 2 venom genes in closely related Sistrurus rattlesnakes with divergent diets. J. Mol. Evol. 2008, 66:151-166.
41. 2 complex. Toxicon 1984, 22:85-98.
42. Greene H.W. Dietary correlates of the origin and radiation of snakes. Amer. Zool. 1983, 23:431-441.
43. Greene H.W. Snakes: The Evolution of Mystery in Nature 1997, University of California Press, Berkeley.
44. 2 myotoxins from Bothrops snake venoms. Toxicon 1995, 33:1405-1424.
45. 2: insights into the mechanisms of local and systemic myotoxicity. Toxicon 2003, 42:915-931.
46. Gutiérrez J.M., Lomonte B., Cerdas L. Isolation and partial characterization of a myotoxin from the venom of the snake Bothrops nummifer. Toxicon 1986, 24:885-894.
47. 2 homologue. Toxicon 2008, 51:80-92.
48. Harris J.B., Cullen M.J. Muscle necrosis caused by snake venoms and toxins. Electron Microsc. Rev. 1990, 3:183-211.
49. 2 and the regeneration of skeletal muscles. Toxicon 2003, 42:933-945.
50. Harvey A.L. Cytolytic toxins. Handbook of Toxinology 1990, 48-53. Marcel Dekker, New York. W.R. Shier, D. Mebs (Eds.).
51. Heluany N.F., Homsi-Brandeburgo M.I., Giglio J.R., Prado-Franceschi J., Rodrigues-Simioni L. Effects induced by bothropstoxin, a component from Bothrops jararacussu snake venom, on mouse and chick muscle preparations. Toxicon 1992, 30:1203.
52. Hodges S.J., Agbaji A.S., Harvey A.L., Hider R.C. Cobra cardiotoxins. Purification, effects on skeletal muscle and structure/activity relationships. Eur. J. Biochem. 1987, 165:373-383.
53. 2 from the venom of the cottonmouth snake at 2.0-å resolution. J. Biol. Chem. 1990, 265:17649-17658.
54. 2 isozyme genes of Protobothrops flavoviridis snake. Gene 2010, 461:15-25.
55. Incerpi S., de Vito P., Luly P., Rufini S. Effect of ammodytin L from Vipera ammodytes on L-6 cells from rat skeletal muscle. Biochim. Biophys. Acta 1995, 1268:137-142.
56. Johnson E.K., Ownby C.L. The role of extracellular ions in the pathogenesis of myonecrosis induced by a myotoxin isolated from broad-banded copperhead (Agkistrodon contortrix laticinctus) venom. Comp. Biochem. Physiol. 1994, 107C:359-366.
57. Kini R.M., Doley R. Structure, function and evolution of three-finger toxins-mini proteins with multiple targets. Toxicon 2010, 56:855-867.
58. 2 enzymes. Toxicon 2003, 42:827-840.
59. Konshina A.G., Boldyrev I.A., Utkin Y.N., Omel'kov A.V., Efremov R.G. Snake cytotoxins bind to membranes via interactions with phosphatidylserine head groups of lipids. PLoS ONE 2011, 6:e19064. 10.1371/journal.pone.0019064.
60. 2 - a hypothesis: the crystal structure of piratoxin II complexed to fatty acid. Biochemistry 2001, 40:28-36.
61. 2 from Agkistrodon acutus venom. J. Biol. Chem. 2003, 278:41400-41408.
62. Lomonte B., Gutiérrez J.M. A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo). Toxicon 1989, 27:725-733.
63. 2 from Viperidae snake venoms: how do they induce skeletal muscle damage?. Acta Chim. Slov. 2011, 58:647-659.
64. 2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling. J. Biol. Chem. 1994, 269:29867-29873.
65. 2 of Bothrops asper snake venom. Toxicon 1994, 32:1359-1369.
66. 2 on mouse endothelial (tEnd) and skeletal muscle (C2C12) cells in vitro. Toxicon 1999, 37:145-158.
67. Lomonte B., Pizarro-Cerdá J., Angulo Y., Gorvel J.P., Moreno E. TyrUTrp-substituted peptide 115-129 of a Lys49 phospholipase A2 expresses enhanced membrane-damaging activities and reproduces its in vivo myotoxic effect. Biochim. Biophys. Acta 1999, 1461:19-26.
68. 2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon 2003, 42:885-901.
69. 2 from snake venoms. Toxicon 2003, 42:307-312.
70. 2 homologues of snake venoms: biological activities and their possible adaptive roles. Prot. Pept. Lett. 2009, 16:860-876.
71. 2 homologues from Viperidae snake venoms: biomimetic activities and potential applications. Curr. Pharm. Design 2010, 16:3220-3224.
72. 2 genes. BMC Evolut. Biol. 2007, 7:2,. 10.1186/1471-2148-7-2.
73. 2: quaternary structure and inhibition mechanism insights. Biochem. Biophys. Res. Comm. 2003, 311:713-720.
74. 2 with lysine in place of aspartate 49. J. Biol. Chem. 1984, 259:13839-13843.
75. 2 homolog complexed with p-bromophenacyl bromide reveals important structural changes associated with the inhibition of myotoxic activity. Biochim. Biophys. Acta 2009, 1794:1583-1590.
76. Mebs D., Ownby C.L. Myotoxic components of snake venoms: their biochemical and biological activities. Pharmac. Ther. 1990, 48:223-236.
77. 2 myotoxins and neurotoxins: common aspects of their mechanisms of action. Cell. Mol. Life Sci. 2008, 65:2897-2912.
78. 2 homologue from Bothrops asper snake venom induces proliferation, apoptosis and necrosis in a lymphoblastoid cell line. Toxicon 2005, 45:651-660.
79. Moura-da-Silva A.M., Cardoso D.F., Tanizaki M. Differences in distribution of myotoxic proteins in venoms from different Bothrops species. Toxicon 1990, 28:1293-1301.
80. 2s's may imply gene duplications. J. Mol. Evol. 1995, 41:174-179.
81. 2 homologue from Atropoides nummifer venom. Acta Cryst. F 2006, 62:423-426.
82. 2 isozyme genes. Proc. Natl. Acad. Sci. USA 1995, 92:5605-5609.
83. 2 from Agkistrodon piscivorus piscivorus snake venom: synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities. Toxicon 2001, 39:1587-1594.
84. 2 isozymes for acquisition of diverse physiological functions. Toxicon 1996, 34:1229-1236.
85. Oguiura N., Boni-Mitake M., Rádis-Baptista G. New view on crotamine, a small basic polypeptide myotoxin from South American rattlesnake venom. Toxicon 2005, 46:363-370.
86. Okazaki T., Ebihara S., Takahashi H., Asada M., Kanda A., Sasaki H. Macrophage colony-stimulating factor induces vascular endothelial growth factor production in skeletal muscle and promotes tumor angiogenesis. J. Immunol. 2005, 174:7531-7538.
87. Ownby C.L., Fletcher J.E., Colberg T.R. Cardiotoxin 1 from cobra (Naja naja atra) venom causes necrosis of seletal muscle in vivo. Toxicon 1993, 31:697-709.
88. 2 from Bothrops asper snake venom: synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region. Eur. J. Biochem. 1998, 253:452-461.
89. Pedersen J.Z., de Arcuri B.F., Morero R., Rufini S. Phospholipase-like myotoxins induce rapid membrane leakage of non-hydrolyzable ether-lipid liposomes. Biochim. Biophys. Acta 1994, 1190:177-180.
90. 2+-independent membrane-damaging activity and increases its toxicity. Biochemistry 2007, 46:12795-12809.
91. 2 homologue from the venom of Bothrops asper. Cell Biochem. Funct. 2011, 29:365-370.
92. 2 from bovine pancreas and Crotalus atrox venom. J. Biol. Chem. 1985, 260:11627-11634.
93. Rissanen T.T., Vajanto I., Hiltunen M.O., Rutanen J., Kettunen M.I., Niemi M., Leppänen P., Turunen M.P., Markkanen J.E., Arve K., Alhava E., Kauppinen R.A., Ylä-Herttuala S. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am. J. Pathol. 2002, 160:1393-1403.
94. Rizzi C.T., Carvalho-de-Souza J.L., Schiavon E., Cassola A.C., Wanke E., Troncone L.R.P. Crotamine inhibits preferentially fast-twitching muscles but is inactive on sodium channels. Toxicon 2007, 50:553-562.
95. Rufini S., Cesaroni P., Desideri A., Farias R., Gubensek F., Gutiérrez J.M., Luly P., Massoud R., Morero R., Pedersen J.Z. Calcium ion independent membrane leakage induced by phospholipase-like myotoxins. Biochemistry 1992, 31:12424-12430.
96. Salvini T.F., Amaral A.C., Miyabara E.H., Turri J.A.O., Danella P.M., Selistre de Araujo H.S. Systemic skeletal muscle necrosis induced by crotoxin. Toxicon 2001, 39:1141-1149.
97. 2 from Agkistrodon piscivorus piscivorus. J. Biol. Chem. 1986, 261:12337-12338.
98. 2 in a complex with a transition-state analogue. Science 1990, 250:1563-1566.
99. 2 from the venom of Agkistrodon piscivorus piscivorus. J. Biol. Chem. 1992, 267:22645-22657.
100. 2 myotoxin from Agkistrodon contortrix laticinctus snake venom. Archs. Biochem. Biophys. 1996, 326:21-30.
101. Sessions A., Horwitz A.F. Differentiation-related differences in the plasma membrane phospholipid assymetry of myogenic and fibrogenic cells. Biochim. Biophys. Acta 1983, 728:103-111.
102. 2 homologue from Bothrops neuwiedi pauloensis venom. Archs. Biochem. Biophys. 2000, 378:201-209.
103. 2 myotoxins from Bothrops snake venoms: structure-function relationship. Curr. Org. Chem. 2004, 8:1677-1690.
104. 2 - not just enzymes. Acta Chim. Slov. 2011, 58:678-688.
105. Strawn L.M., McMahon G., App H., Schreck R., Kuchler W.R., Longhi M.P., Hui T.H., Tang C., Levitzki A., Gazit A., Chen I., Keri G., Orfi L., Risau W., Flamme I., Ullrich A., Hirth K.P., Shawver L.K. Flk-1 as a target for tumor growth inhibition. Cancer Res. 1996, 56:3540-3545.
106. 2 from the venoms of rattlesnakes and other pit vipers. Archs. Biochem. Biophys. 2001, 394:236-244.
107. Van den Eijnde S.M., Boshart L., Reutelingsperger C.P.M., De Zeeuw C.I., Vermeij-Keers C.I.C. Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis. Cell Death Differ. 1997, 4:311-316.
108. Van den Eijnde S., van den Hoff M.J.B., Reutelingsperger C.P.M., van Heerde W.L., Henfling M.E.R., Vermeij-Keers C., Schutte B., Borgers M., Ramaekers F.C.S. Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J. Cell Sci. 2001, 114:3631-3642.
109. 2 homologue from the venom of the snake Bothrops asper: evidence of rapid plasma membrane damage and a dual role for extracellular calcium. Toxicol. In Vitro 2007, 21:1382-1389.
110. 2: biological and membrane-disrupting activities in the absence of catalysis. Biochem. J. 2002, 362:89-96.
111. Warrell D.A. Snakebite. Lancet 2010, 375:77-88.
112. 2. J. Biol. Chem. 2005, 280:29989-29992.
113. Zachowski A. Phospholipids in animal eukaryotic membranes: transverse assymetry and movement. Biochem. J. 1993, 294:1-14.